![]() Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | ![]() Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. | ![]() Abiogen Pharma Abiogen Pharma is a specialist pharmaceutical company that focuses on bone metabolism and rare diseases. | |
Founding Date | Founding Date N/A | Founding Date 1988 | Founding Date 1997 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Leiden, NL HQ Leiden, NL | Locations Pisa, IT HQ |
Employees | Employees 29723% increase | Employees 404 | Employees 351 |
Valuation ($) | Valuation ($) 1.1 b | Valuation ($) 590.3 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) $376.1m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $41.6m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €53m (FY, 2025) | Gross profit $341m (FY, 2025) | Gross profit N/A |
Net income | Net income (€196.4m) (FY, 2025) | Net income $2.5m (FY, 2025) | Net income N/A |

Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.
View company
Abiogen Pharma is a specialist pharmaceutical company that focuses on bone metabolism and rare diseases.
View company